• Seeking Alpha

Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq’s Stockholders’ Equity Standard

Seeking Alpha / 2 hours ago 4 Views

Salarius Pharmaceuticals granted additional extention to regain Nasdaq compliance
Read more
  • Source:
  • GlobeNewswire - News about Public Companies
Previous post
Vivos Inc. Submitted the Investigational Device Exemption (IDE) Application for Human Clinical Trials at Mayo Clinic
Next post
Neurocrine Biosciences Presents One-Year Data Showing Sustained Efficacy of CRENESSITY® (crinecerfont) in Adult Patients, at ENDO 2025

Comments

Just Posted

  • Revival Gold Announces Upsize of Financing for a Total of $27 Million

    3 hours from now

  • Presidio Property Trust Announces Pricing of a Registered Direct Offering of Common Stock

    3 hours from now

  • Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue

    3 hours from now

  • Solvay revises its 2025 underlying EBITDA outlook and confirms its Free cash flow guidance

    2 hours from now

  • Solvay herziet haar onderliggende EBITDA vooruitzichten voor 2025 en bevestigt de Vrije kasstroom prognose

    2 hours from now

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Reviews

Categories

  • Seeking Alpha 846

Categories

  • Seeking Alpha 846

Pages

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Copyright News That Move � 2018. All Rights Reserved

  • Seeking Alpha
  • Trade Halts